(Q33558937)

English

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

Anne-Geneviève Marcelin

1

object named as

Anne-Genevieve Marcelin

0 references

Magali Bouvier-Alias

12

object named as

Magali Bouvier-Alias

1 reference

Europe PubMed Central

28 July 2017

Philippe Flandre

object named as

Philippe Flandre

2

0 references

object named as

Sylvie Rogez

18

0 references

ANRS AC11 Resistance Study Group

24

object named as

ANRS AC11 Resistance Study Group

1 reference

Europe PubMed Central

28 July 2017

3

object named as

Diane Descamps

1 reference

Europe PubMed Central

28 July 2017

6

object named as

Jacques Izopet

1 reference

Europe PubMed Central

28 July 2017

Charlotte Charpentier

5

object named as

Charlotte Charpentier

1 reference

Europe PubMed Central

28 July 2017

1 reference

ORCID Public Data File 2021

Constance Delaugerre

9

object named as

Constance Delaugerre

1 reference

Europe PubMed Central

28 July 2017

Mary-Anne Trabaud

7

object named as

Mary-Anne Trabaud

1 reference

Europe PubMed Central

28 July 2017

Catherine Tamalet

10

object named as

Catherine Tamalet

1 reference

Europe PubMed Central

28 July 2017

Jacqueline Cottalorda

11

object named as

Jacqueline Cottalorda

1 reference

Europe PubMed Central

28 July 2017

Dominique Bettinger

13

object named as

Dominique Bettinger

1 reference

Europe PubMed Central

28 July 2017

Annick Ruffault

15

object named as

Annick Ruffault

1 reference

Europe PubMed Central

28 July 2017

16

object named as

Chakib Alloui

1 reference

Europe PubMed Central

28 July 2017

Cécile Henquell

17

object named as

Cecile Henquell

1 reference

Europe PubMed Central

28 July 2017

19

object named as

Francis Barin

1 reference

Europe PubMed Central

28 July 2017

Anne Signori-Schmuck

20

object named as

Anne Signori-Schmuck

1 reference

Europe PubMed Central

28 July 2017

21

object named as

Sophie Vallet

1 reference

Europe PubMed Central

28 July 2017

Bernard Masquelier

22

object named as

Bernard Masquelier

1 reference

Europe PubMed Central

28 July 2017

author name string

Laurence Morand-Joubert

4

1 reference

Europe PubMed Central

28 July 2017

Henia Saoudin

8

1 reference

Europe PubMed Central

28 July 2017

Georges Dos Santos

14

1 reference

Europe PubMed Central

28 July 2017

Vincent Calvez

23

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

9 November 2009

1 reference

Europe PubMed Central

28 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

28 July 2017

54

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

72-77

1 reference

Europe PubMed Central

28 July 2017

Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Update of the Drug Resistance Mutations in HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

21 June 2018

Darunavir in patients with advanced HIV and multiresistance. The POWER, DUET and BENCHMRK studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Validation of a model for the complex of HIV-1 reverse transcriptase with nonnucleoside inhibitor TMC125.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 V

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2798499

31 October 2018

Identifiers

10.1128/AAC.01051-09

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33558937&oldid=1774602171"